Skip to content
Biodatica
Start free

Investigator

James R. Heath

INSTITUTE FOR SYSTEMS BIOLOGY · funded by NCI

Companies
2

Resolved onto their grants.

Grants
5

Federal awards on file.

Non-dilutive funding
$4.4M

Summed across those awards.

First award
Sep 16, 2021

Latest Sep 22, 2022.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. U54

    Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)

    $2.6M

    Sep 22, 2022NCIINSTITUTE FOR SYSTEMS BIOLOGYNIH RePORTER · 11191397 (opens the source filing in a new tab)

  2. U54

    Administrative Core

    $414k

    Sep 22, 2022NCIINSTITUTE FOR SYSTEMS BIOLOGYNIH RePORTER · 11191414 (opens the source filing in a new tab)

  3. U54

    PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations

    $801k

    Sep 22, 2022NCIINSTITUTE FOR SYSTEMS BIOLOGYNIH RePORTER · 11191418 (opens the source filing in a new tab)

  4. U54

    Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)

    $145k

    Sep 22, 2022NCIINSTITUTE FOR SYSTEMS BIOLOGYNIH RePORTER · 11220443 (opens the source filing in a new tab)

  5. R01

    Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization

    $524k

    Sep 16, 2021NCIINSTITUTE FOR SYSTEMS BIOLOGYNIH RePORTER · 11121834 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources